Combined cell-based therapy strategies for the treatment of Parkinson’s disease: focus on mesenchymal stromal cells

Parkinson’s disease is a neurodegenerative condition characterized by motor impairments caused by the selective loss of dopaminergic neurons in the substantia nigra. Levodopa is an effective and well-tolerated dopamine replacement agent. However, levodopa provides only symptomatic improvements, with...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Pallares, Jannette, García-Garrote, María, Parga, Juan A., Labandeira-García, José Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727452/
https://www.ncbi.nlm.nih.gov/pubmed/36018150
http://dx.doi.org/10.4103/1673-5374.350193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727452/
https://www.ncbi.nlm.nih.gov/pubmed/36018150
http://dx.doi.org/10.4103/1673-5374.350193

Ejemplares similares